102 related articles for article (PubMed ID: 35068445)
1. Exosome-delivered circular RNA DLGAP4 induces chemoresistance via miR-143-HK2 axis in neuroblastoma.
Tan WQ; Yuan L; Wu XY; He CG; Zhu SC; Ye M
Cancer Biomark; 2022; 34(3):375-384. PubMed ID: 35068445
[TBL] [Abstract][Full Text] [Related]
2. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA DLGAP4 Ameliorates Ischemic Stroke Outcomes by Targeting miR-143 to Regulate Endothelial-Mesenchymal Transition Associated with Blood-Brain Barrier Integrity.
Bai Y; Zhang Y; Han B; Yang L; Chen X; Huang R; Wu F; Chao J; Liu P; Hu G; Zhang JH; Yao H
J Neurosci; 2018 Jan; 38(1):32-50. PubMed ID: 29114076
[TBL] [Abstract][Full Text] [Related]
4. Circular RNA DLGAP4 alleviates sevoflurane-induced neurotoxicity by regulating miR-9-5p/Sirt1/BDNF pathway.
Zhang D; Wu L; Ma L; Wang J; Niu L; He P
Exp Cell Res; 2023 Dec; 433(2):113861. PubMed ID: 38000773
[TBL] [Abstract][Full Text] [Related]
5. Circular RNA circDLGAP4 exerts neuroprotective effects via modulating miR-134-5p/CREB pathway in Parkinson's disease.
Feng Z; Zhang L; Wang S; Hong Q
Biochem Biophys Res Commun; 2020 Feb; 522(2):388-394. PubMed ID: 31761328
[TBL] [Abstract][Full Text] [Related]
6. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
7. Circular RNA circDLGAP4 is involved in lung cancer development through modulating microRNA-143/CDK1 axis.
Wang B; Hua P; Zhao B; Li J; Zhang Y
Cell Cycle; 2020 Aug; 19(16):2007-2017. PubMed ID: 32646340
[TBL] [Abstract][Full Text] [Related]
8. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
[TBL] [Abstract][Full Text] [Related]
9. Exosomal circ_DLGAP4 promotes diabetic kidney disease progression by sponging miR-143 and targeting ERBB3/NF-κB/MMP-2 axis.
Bai S; Xiong X; Tang B; Ji T; Li X; Qu X; Li W
Cell Death Dis; 2020 Nov; 11(11):1008. PubMed ID: 33230102
[TBL] [Abstract][Full Text] [Related]
10. Circ-PRMT5 enhances the proliferation, migration and glycolysis of hepatoma cells by targeting miR-188-5p/HK2 axis.
Ding Z; Guo L; Deng Z; Li P
Ann Hepatol; 2020; 19(3):269-279. PubMed ID: 32089501
[TBL] [Abstract][Full Text] [Related]
11. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
Zhu X; Du J; Gu Z
Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
[TBL] [Abstract][Full Text] [Related]
12. Circ-CUX1 Accelerates the Progression of Neuroblastoma via miR-16-5p/DMRT2 Axis.
Zhang X; Zhang J; Liu Q; Zhao Y; Zhang W; Yang H
Neurochem Res; 2020 Dec; 45(12):2840-2855. PubMed ID: 33000435
[TBL] [Abstract][Full Text] [Related]
13. Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2.
Zheng Z; Ma X; Li H
J Cell Mol Med; 2020 Jul; 24(13):7531-7537. PubMed ID: 32410389
[TBL] [Abstract][Full Text] [Related]
14. circCUX1 promotes neuroblastoma progression and glycolysis by regulating the miR-338-3p/PHF20 axis.
Wang Y; Niu Q; Dai J; Shi H; Zhang J
Gen Physiol Biophys; 2021 Jan; 40(1):17-29. PubMed ID: 33655888
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
16. Exosomal transfer of miR-501 confers doxorubicin resistance and tumorigenesis via targeting of BLID in gastric cancer.
Liu X; Lu Y; Xu Y; Hou S; Huang J; Wang B; Zhao J; Xia S; Fan S; Yu X; Du Y; Hou L; Li Z; Ding Z; An S; Huang B; Li L; Tang J; Ju J; Guan H; Song B
Cancer Lett; 2019 Sep; 459():122-134. PubMed ID: 31173853
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway.
Zhang Y; Liu Y; Xu X
J Cell Biochem; 2018 Jul; 119(7):6296-6308. PubMed ID: 29663500
[TBL] [Abstract][Full Text] [Related]
18. Exosomal Circ-XIAP Promotes Docetaxel Resistance in Prostate Cancer by Regulating miR-1182/TPD52 Axis.
Zhang H; Li M; Zhang J; Shen Y; Gui Q
Drug Des Devel Ther; 2021; 15():1835-1849. PubMed ID: 33976535
[TBL] [Abstract][Full Text] [Related]
19. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
20. Hsa_circ_0069094 accelerates cell malignancy and glycolysis through regulating the miR-591/HK2 axis in breast cancer.
Xing Z; Wang X; Liu J; Zhang M; Feng K; Wang X
Cell Signal; 2021 Mar; 79():109878. PubMed ID: 33309838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
